Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gadducci

Showing results (71-80 of 179) with videos related to

Pageof 18
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 22, 2002
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapyE Sartori, A Gadducci, F Landoni, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|January 1, 1991
CA 195: a new monoclonal antibody-defined Lea blood group-related tumor marker in patients with epithelial ovarian cancerA Gadducci, M Ferdeghini, C Prontera, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 2007
Follow-up strategies in gynecological oncology: searching appropriatenessP Zola, L Fuso, S Mazzola, et al.
European Journal of Gynaecological Oncology|January 1, 1988
The association of ultrasonography and CA-125 test in the preoperative evaluation of ovarian carcinomaA Gadducci, P Capriello, T Bartolini, et al.
Anticancer Research|March 12, 1998
Platinum compounds and paclitaxel in advanced epithelial ovarian cancerA Gadducci, I Brunetti, S Cosio, et al.
European Journal of Gynaecological Oncology|August 24, 2013
Analysis of failures and clinical outcome of advanced epithelial ovarian cancer in patients with microscopic residual disease at second-look reassessment following primary cytoreductive surgery and first-line platinum-based chemotherapyA Gadducci, R Tana, F Landoni, et al.
European Journal of Gynaecological Oncology|January 1, 1990
A comparison of the usefulness of serum measurements of CA 125, CA 50 and TATI in patients with malignant and benign gynecological pathologyA Gadducci, M Ferdeghini, V Facchini, et al.
European Journal of Gynaecological Oncology|January 1, 1990
A comparative evaluation of the ability of serum CA 125, CA 19-9, CA 15-3, CA 50, CA 72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinomaA Gadducci, M Ferdeghini, T Ceccarini, et al.
European Journal of Gynaecological Oncology|January 1, 1984
Transrectal ultrasonography and cervical neoplasia. A preliminary reportG Di Candio, A Campatelli, F Mosca, et al.
The Journal of Nuclear Medicine and Allied Sciences|July 1, 1989
The trend of serum CA125 levels during the first three courses of chemotherapy as a predictor of second-look findings in patients with ovarian carcinomaA Gadducci, M Ferdeghini, T Bartolini, et al.
Pageof 18

Showing results (71-80 of 179) with videos related to

Sort By:
Pageof 18
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 22, 2002
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapyE Sartori, A Gadducci, F Landoni, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|January 1, 1991
CA 195: a new monoclonal antibody-defined Lea blood group-related tumor marker in patients with epithelial ovarian cancerA Gadducci, M Ferdeghini, C Prontera, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 2007
Follow-up strategies in gynecological oncology: searching appropriatenessP Zola, L Fuso, S Mazzola, et al.
European Journal of Gynaecological Oncology|January 1, 1988
The association of ultrasonography and CA-125 test in the preoperative evaluation of ovarian carcinomaA Gadducci, P Capriello, T Bartolini, et al.
Anticancer Research|March 12, 1998
Platinum compounds and paclitaxel in advanced epithelial ovarian cancerA Gadducci, I Brunetti, S Cosio, et al.
European Journal of Gynaecological Oncology|August 24, 2013
Analysis of failures and clinical outcome of advanced epithelial ovarian cancer in patients with microscopic residual disease at second-look reassessment following primary cytoreductive surgery and first-line platinum-based chemotherapyA Gadducci, R Tana, F Landoni, et al.
European Journal of Gynaecological Oncology|January 1, 1990
A comparison of the usefulness of serum measurements of CA 125, CA 50 and TATI in patients with malignant and benign gynecological pathologyA Gadducci, M Ferdeghini, V Facchini, et al.
European Journal of Gynaecological Oncology|January 1, 1990
A comparative evaluation of the ability of serum CA 125, CA 19-9, CA 15-3, CA 50, CA 72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinomaA Gadducci, M Ferdeghini, T Ceccarini, et al.
European Journal of Gynaecological Oncology|January 1, 1984
Transrectal ultrasonography and cervical neoplasia. A preliminary reportG Di Candio, A Campatelli, F Mosca, et al.
The Journal of Nuclear Medicine and Allied Sciences|July 1, 1989
The trend of serum CA125 levels during the first three courses of chemotherapy as a predictor of second-look findings in patients with ovarian carcinomaA Gadducci, M Ferdeghini, T Bartolini, et al.
Pageof 18